Evidence map›Paper›PMID 21703863›Full record

ReviewTrends in endocrinology and metabolism: TEM2011

Stressed out about obesity: IRE1α-XBP1 in metabolic disorders.

Haibo Sha, Yin He, Liu Yang, Ling Qi

Abstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. World journal of gastroenterology · 2025
    Article
  7. Emerging role of IRE1α in vascular diseases.Journal of cell communication and signaling · 2024
    Review
  8. Article
  9. Non-canonical activation of IRE1α duringbioRxiv : the preprint server for biology · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Phosphorylation at SerThe Journal of biological chemistry · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Haibo ShaDivision of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
Yin He
Liu Yang
Ling Qi
Cornell University · US

Funding

Adipokine Signaling in MacrophagesR01DK082582 · NIDDK · CORNELL UNIVERSITY · PI QI, LING · 2009 to 2013
$1.6M
NIDDK NIH HHS R01 DK082582NIDDK NIH HHS R01DK082582
6 · The paper itself

Abstract

The global obesity epidemic is associated with a series of health-threatening diseases including type 2 diabetes. Accumulating evidence suggest that the physiology and homeostasis of the endoplasmic reticulum (ER) is intimately involved in the underlying mechanisms linking obesity and diabetes. Specifically, recent studies indicate a crucial role for the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway, the most conserved branch of the unfolded protein response (UPR), in glucose and lipid metabolism as well as in insulin function. Focusing on the IRE1α-XBP1 pathway, we review recent advances in our understanding of the role of UPR in obesity and obesity-associated metabolic disorders.

Indexed as

AnimalsDiabetes Mellitus, Type 2DNA-Binding ProteinsEndoplasmic ReticulumEndoribonucleasesInsulin ResistanceMiceObesityProtein Serine-Threonine KinasesRegulatory Factor X Transcription FactorsTranscription FactorsUnfolded Protein ResponseX-Box Binding Protein 1DNA-Binding ProteinsEndoribonucleasesErn1 protein, mouseProtein Serine-Threonine KinasesRegulatory Factor X Transcription FactorsTranscription FactorsX-Box Binding Protein 1Xbp1 protein, mouse

Identifiers

PMID21703863
PMCPMC3163776
OpenAlexW2030778459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.